Potentially hazardous drugs will be withdrawn from the market at the first sign of a problem, according to a draft action plan.The system would require drug makers to pull problematic products off the shelves even before results of lab examinations are out, said Yan Jiangying, spokeswoman for the State Food and Drug Administration (SFDA).
